Nuclear Jak2 and transcription factor NF1-C2: A novel mechanism of prolactin signaling in mammary epithelial cells

Molecular and Cellular Biology

Volumn 26, Issue 15, 2006, Pages 5663-5674

  Nilsson, Jeanette ^a   Bjursell, Gunnar ^a   Kannius Janson, Marie ^a  

^a Box 462 ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLESTERASE; JANUS KINASE 2; NUCLEAR FACTOR I; NUCLEAR PROTEIN; PROLACTIN; PROLACTIN RECEPTOR; PROTEASOME; PROTEIN P53; STAT5 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NF1 C2; TRIACYLGLYCEROL LIPASE; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST EPITHELIUM; CELL MEMBRANE; CELL NUCLEUS; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; ENZYME LOCALIZATION; ENZYME REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CELL NUCLEUS; EPITHELIAL CELLS; HUMANS; JANUS KINASE 2; LIPASE; MAMMARY GLANDS, HUMAN; MICE; NFI TRANSCRIPTION FACTORS; PHOSPHORYLATION; PROLACTIN; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; TWO-HYBRID SYSTEM TECHNIQUES; TYROSINE;

EID: 33746531672     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.02095-05     Document Type: Article

References (38)

1. Alexander, W. S., R. Starr, D. Metcalf, S. E. Nicholson, A. Farley, A. G. Elefanty, M. Brysha, B. T. Kile, R. Richardson, M. Baca, J. G. Zhang, T. A. Willson, E. M. Viney, N. S. Sprigg, S. Rakar, J. Corbin, S. Mifsud, L. DiRago, D. Cary, N. A. Nicola, and D. J. Hilton. 1999. Suppressors of cytokine signaling (SOCS): negative regulators of signal transduction. J. Leukoc. Biol. 66:588-592.
2. al-Sakkaf, K. A., P. R. Dobson, and B. L. Brown. 1997. Prolactin induced tyrosine phosphorylation of p59fyn may mediate phosphatidylinositol 3-kinase activation in Nb2 cells. J. Mol. Endocrinol. 19:347-350.
3. Ausubel, F., R. Brent, R. Kingston, D. Moore, J. G. Seidman, J. Smith, and K. Struhl. 1987. Current protocols in molecular biology. Wiley Interscience, New York, N.Y.
4. Berlanga, J. J., J. A. Fresno Vara, J. Martin-Perez, and J. P. Garcia-Ruiz. 1995. Prolactin receptor is associated with c-src kinase in rat liver. Mol. Endocrinol. 9:1461-1467.
5. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
6. Ciechanover, A. 1994. The ubiquitin-proteasome proteolytic pathway. Cell 79:13-21.
7. Concin, N., C. Zeillinger, D. Tong, M. Stimpfl, M. Konig, D. Printz, F. Stonek, C. Schneeberger, L. Hefler, C. Kainz, S. Leodolter, O. A. Haas, and R. Zeillinger. 2003. Comparison of p53 mutational status with mRNA and protein expression in a panel of 24 human breast carcinoma cell lines. Breast Cancer Res. Treat. 79:37-46.
8. Cui, Y., G. Riedlinger, K. Miyoshi, W. Tang, C. Li, C. X. Deng, G. W. Robinson, and L. Hennighausen. 2004. Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. Mol. Cell. Biol. 24:8037-8047.
9. Das, R., and B. K. Vonderhaar. 1996. Activation of raf-1, MEK, and MAP kinase in prolactin responsive mammary cells. Breast Cancer Res. Treat. 40:141-149.
10. Das, R., and B. K. Vonderhaar. 1996. Involvement of SHC, GRB2, SOS and RAS in prolactin signal transduction in mammary epithelial cells. Oncogene 13:1139-1145.
11. Goldberg, A. L., and K. L. Rock. 1992. Proteolysis, proteasomes and antigen presentation. Nature 357:375-379.
12. He, K., K. Loesch, J. W. Cowan, X. Li, L. Deng, X. Wang, J. Jiang, and S. J. Frank. 2005. Janus kinase 2 enhances the stability of the mature growth hormone receptor. Endocrinology 146:4755-4765.
13. Houdebine, L. M., J. Djiane, I. Dusanter-Fourt, P. Martel, P. A. Kelly, E. Devinoy, and J. L. Servely. 1985. Hormonal action controlling mammary activity. J. Dairy Sci. 68:489-500.
14. Johansson, E. M., M. Kannius-Janson, G. Bjursell, and J. Nilsson. 2003. The p53 tumor suppressor gene is regulated in vivo by nuclear factor 1-C2 in the mouse mammary gland during pregnancy. Oncogene 22:6061-6070.
15. Johansson, E. M., M. Kannius-Janson, A. Gritli-Linde, G. Bjursell, and J. Nilsson. 2005. Nuclear factor 1-C2 is regulated by prolactin and shows a distinct expression pattern in the mouse mammary epithelial cells during development. Mol. Endocrinol. 19:992-1003.
16. Kannius-Janson, M., E. M. Johansson, G. Bjursell, and J. Nilsson. 2002. Nuclear factor 1-C2 contributes to the tissue-specific activation of a milk protein gene in the differentiating mammary gland. J. Biol. Chem. 277:17589-17596.
17. Kannius-Janson, M., U. Lidberg, K. Hulten, A. Gritli-Linde, G. Bjursell, and J. Nilsson. 1998. Studies of the regulation of the mouse carboxyl ester lipase gene in mammary gland. Biochem. J. 336:577-585.
18. Kelly, P. A., A. Bachelot, C. Kedzia, L. Hennighausen, C. J. Ormandy, J. J. Kopchick, and N. Binart. 2002. The role of prolactin and growth hormone in mammary gland development. Mol. Cell. Endocrinol. 197:127-131.
19. Lidberg, U., M. Kannius-Janson, J. Nilsson, and G. Bjursell. 1998. Transcriptional regulation of the human carboxyl ester lipase gene in exocrine pancreas. Evidence for a unique tissue-specific enhancer. J. Biol. Chem. 273:31417-31426.
20. Lindeman, G. J., S. Wittlin, H. Lada, M. J. Naylor, M. Santamaria, J. G. Zhang, R. Starr, D. J. Hilton, W. S. Alexander, C. J. Ormandy, and J. Visvader. 2001. SOCS1 deficiency results in accelerated mammary gland development and rescues lactation in prolactin receptor-deficient mice. Genes Dev. 15:1631-1636.
21. Llovera, M., P. Touraine, P. A. Kelly, and V. Goffin. 2000. Involvement of prolactin in breast cancer: redefining the molecular targets. Exp. Gerontol. 35:41-51.
22. Lobie, P. E., B. Ronsin, O. Silvennoinen, L. A. Haldosen, G. Norstedt, and G. Morel. 1996. Constitutive nuclear localization of Janus kinases 1 and 2. Endocrinology 137:4037-4045.
23. Miyoshi, K., J. M. Shillingford, G. H. Smith, S. L. Grimm, K. U. Wagner, T. Oka, J. M. Rosen, G. W. Robinson, and L. Hennighausen. 2001. Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium. J. Cell Biol. 155:531-542.
24. Nevalainen, M. T., J. Xie, L. Bubendorf, K. U. Wagner, and H. Rui. 2002. Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium. Mol. Endocrinol. 16:1108-1124.
25. Ormandy, C. J., A. Camus, J. Barra, D. Damotte, B. Lucas, H. Buteau, M. Edery, N. Brousse, C. Babinet, N. Binart, and P. A. Kelly. 1997. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev. 11:167-178.
26. Palombella, V. J., O. J. Rando, A. L. Goldberg, and T. Maniatis. 1994. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 78:773-785.
27. Ram, P. A., and D. J. Waxman. 1997. Interaction of growth hormone-activated STATs wilh SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase. J. Biol. Chem. 272:17694-17702.
28. Royer, Y., J. Staerk, M. Costuleanu, P. J. Courtoy, and S. N. Constantinescu. 2005. Janus kinases affect thrombopoietin receptor cell surface localization and stability. J. Biol. Chem. 280:27251-27261.
29. Shillingford, J. M., K. Miyoshi, G. W. Robinson, S. L. Grimm, J. M. Rosen, H. Neubauer, K. Pfeffer, and L. Hennighausen. 2002. Jak2 is an essential tyrosine kinase involved in pregnancy-mediated development of mammary secretory epithelium. Mol. Endocrinol. 16:563-570.
30. Sorenson, R. L., and L. E. Stout. 1995. Prolactin receptors and JAK2 in islets of Langerhans: an immunohistochemical analysis. Endocrinology 136:4092-4098.
31. Stancovski, I., H. Gonen, A. Orian, A. L. Schwartz, and A. Ciechanover. 1995. Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes. Mol. Cell. Biol. 15:7106-7116.
32. Touitou, R., J. Richardson, S. Bose, M. Nakanishi, J. Rivett, and M. J. Allday. 2001. A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome. EMBO J. 20:2367-2375.
33. Ungureanu, D., P. Saharinen, I. Junttila, D. J. Hilton, and O. Silvennoinen. 2002. Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1. Mol. Cell. Biol. 22:3316-3326.
34. Watson, C. J. 2001. Stat transcription factors in mammary gland development and tumorigenesis. J. Mammary Gland Biol. Neoplasia 6:115-127.
35. Watson, C. J., and T. G. Burdon. 1996. Prolactin signal transduction mechanisms in the mammary gland: the role of the Jak/Stat pathway. Rev. Reprod. 1:1-5.
36. Xie, J., M. J. LeBaron, M. T. Nevalainen, and H. Rui. 2002. Role of tyrosine kinase Jak2 in prolactin-induced differentiation and growth of mammary epithelial cells. J. Biol. Chem. 277:14020-14030.
37. Yasukawa, H., H. Misawa, H. Sakamoto, M. Masuhara, A. Sasaki, T. Wakioka, S. Ohtsuka, T. Imaizumi, T. Matsuda, J. N. Ihle, and A. Yoshimura. 1999. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 18:1309-1320.
38. Yu, C. L., and S. J. Burakoff. 1997. Involvement of proteasomes in regulating Jak-STAT pathways upon interleukin-2 stimulation. J. Biol. Chem. 272:14017-14020.